ImmuLisa Enhanced Centromere Antibody ELISA— 510(k) K151559

Substantially Equivalent

Immco Diagnostics, Inc.

FDA 510(k) clearance K151559 for ImmuLisa Enhanced Centromere Antibody ELISA, Substantially Equivalent on 2016-03-11. Applicant: Immco Diagnostics, Inc..

Clearance details

Applicant
Immco Diagnostics, Inc.
Product code
Code LJM
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Buffalo, NY, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.